Brought to you by 
NeoTract brings in $23.7mm so far through its Series B; now totals $28.1mm
07 Sep 2017
Executive Summary
NeoTract (surgical devices for urological conditions) has raised $23.7mm of a proposed $25.2mm Series B round from returning shareholder New Enterprise Associates, new investor Johnson & Johnson Development Corp., and one other backer.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
NeoTract brings in $23.7mm so far through its Series B; now totals $28.1mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice